Fish-oil fatty acid supplementation in mixed cryoglobulinemia: a preliminary report.
OBJECTIVE
Since fish oils seem to play a potential role in the treatment of inflammatory disorders by inhibiting arachidonic acid metabolism, the purpose of this study was to determine their therapeutic efficacy in mixed cryoglobulinemia (MC), an inflammatory condition caused by the deposition of immune complexes in vessel walls.


METHODS
In an 8-week double-blind randomized trial, ten MC patients received a daily dietary supplement of 3 gm of eicosapentaenoic acid (EPA) and 2 gm of docosahexenoic acid (DHA), while 10 other MC patients received placebo (olive oil). The severity of purpura, arthralgias, paresthesias, asthenia and Raynaud's phenomenon were monitored daily, and serological assays were performed at the beginning of the study, at the end of the treatment period, and after 4 weeks of wash-out.


RESULTS
No significant differences were found between the two groups with regard to the clinical symptoms, although the percentage of patients who reported a clinical improvement was higher in the group treated with fish oils. As for the serological parameters, no variation was found in the placebo group, while in the group receiving fish oils a significant decrease in cryocrit and rheumatoid factor levels was observed, which in the case of rheumatoid factor persisted at the end of the wash-out period.


CONCLUSIONS
Under the experimental conditions employed in this study, we could not demonstrate a significant improvement in clinical symptoms in patients with mixed cryoglobulinemia treated with fish oils. However, since our results indicated some improvement in the serological parameters potentially involved in the pathogenesis of the disorder, further studies are warranted to establish the optimal dose and duration of fish oil supplementation in the treatment of MC.
Institute of Clinical Medicine, University of Ancona, Italy.
M
M
Candela
G
G
Cherubini
F
F
Chelli
G
G
Danieli
A
A
Gabrielli
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003449:Cryoglobulinemia / Q000178:diet therapy* / Q000503:physiopathology; D004041:Dietary Fats / Q000627:therapeutic use*; D004311:Double-Blind Method; D005227:Fatty Acids / Q000627:therapeutic use*; D005260:Female; D005395:Fish Oils / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010292:Paresthesia / Q000178:diet therapy / Q000503:physiopathology; D011693:Purpura / Q000178:diet therapy / Q000503:physiopathology; D016896:Treatment Outcome
D004041:Dietary Fats; D005227:Fatty Acids; D005395:Fish Oils